Date published: 2026-1-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fusidic acid (CAS 6990-06-3)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(3α,4α,8α,9β,11α,13α,147β,167β,17Z)-16-(Acetyloxy)-3,11-dihydroxy-29-nordammara-17(20),24-dien-21-oic Acid; Flucidin; Fucithalmic; Fusidinic Acid; NSC 56192; Ramycin; SQ 16603
Application:
Fusidic acid is a bacteriostatic antibiotic that only works on gram-positive bacteria
CAS Number:
6990-06-3
Purity:
98%
Molecular Weight:
516.71
Molecular Formula:
C31H48O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Fusidic acid, with the CAS number 6990-06-3, is a steroidal antibiotic compound derived from the fungus Fusidium coccineum. This molecule is distinguished by its unique steroidal structure, which plays a crucial role in its mode of action against bacterial cells. Fusidic acid operates by selectively binding to the elongation factor G (EF-G) found in the bacterial ribosome. This interaction effectively blocks the translocation step of protein synthesis, where EF-G is instrumental in advancing the mRNA and tRNA through the ribosome during protein assembly. By inhibiting this critical step, fusidic acid disrupts protein synthesis, leading to the cessation of bacterial growth. This specific mechanism makes fusidic acid a valuable tool in research, particularly in the study of bacterial protein synthesis and ribosome function. It provides a means to probe the dynamics of the ribosome′s action and to understand the role of various bacterial elongation factors in protein synthesis. Additionally, research involving fusidic acid has expanded into studying the potential for resistance mechanisms that bacteria can develop, which is crucial for the ongoing development of strategies to combat bacterial infections. This research has broad implications for understanding the fundamentals of bacterial physiology and the development of antibacterial agents.


Fusidic acid (CAS 6990-06-3) References

  1. Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10.  |  Di Marco, R., et al. 1999. J Autoimmun. 13: 187-95. PMID: 10479387
  2. Fusidic acid in vitro activity.  |  Collignon, P. and Turnidge, J. 1999. Int J Antimicrob Agents. 12 Suppl 2: S45-58. PMID: 10528786
  3. Fusidic acid non-antibacterial activity.  |  Christiansen, K. 1999. Int J Antimicrob Agents. 12 Suppl 2: S73-8. PMID: 10528789
  4. Fusidic acid: a new antibiotic.  |  GODTFREDSEN, WO., et al. 1962. Nature. 193: 987. PMID: 13899435
  5. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.  |  Howden, BP. and Grayson, ML. 2006. Clin Infect Dis. 42: 394-400. PMID: 16392088
  6. Molecular characterization of non-aureus staphylococci and Mammaliicoccus from Hipposideros bats in Southwest Nigeria.  |  Adesoji, TO., et al. 2024. Sci Rep. 14: 6899. PMID: 38519524
  7. Repurposing fusidic acid as an antimicrobial against enterococci with a low probability of resistance development.  |  Abdelmassih, MM., et al. 2024. Int Microbiol.. PMID: 38532184
  8. Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics.  |  Tanaka, N., et al. 1968. Biochem Biophys Res Commun. 30: 278-83. PMID: 4296678
  9. On the mode of action of fusidic acid.  |  Harvey, CL., et al. 1966. Biochemistry. 5: 3320-7. PMID: 5339551
  10. Fusidic acid suppresses nitric oxide toxicity in pancreatic islet cells.  |  Burkart, V., et al. 1994. Biochem Pharmacol. 48: 1379-85. PMID: 7945436

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Fusidic acid, 1 g

sc-215065
1 g
$292.00